BioLineRx (BLRX) Inventory (2023 - 2025)

BioLineRx's Inventory history runs 3 years deep, the most recent figure standing at $2.1 million for Q4 2025.

• On a quarterly basis, Inventory fell 31.7% year-over-year to $2.1 million in Q4 2025; TTM through Dec 2025 was $2.1 million, a 31.7% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, down 31.7% from the prior year.
• Inventory declined to $2.1 million in Q4 2025 per BLRX's latest filing, from $2.2 million in the prior quarter.
• Across five years, Inventory topped out at $3.6 million in Q2 2024 and bottomed at $1.4 million in Q3 2023.
• The 3-year median for Inventory is $2.9 million (2024), against an average of $2.7 million.
• Across the five-year window, Inventory soared 162.13% in 2024 and slumped 38.46% in 2025, its largest moves.
• Year by year, Inventory stood at $2.0 million in 2023, then jumped by 61.03% to $3.1 million in 2024, then tumbled by 31.7% to $2.1 million in 2025.
• Per Business Quant, the three latest BLRX Inventory figures stand at $2.1 million (Q4 2025), $2.2 million (Q3 2025), and $2.8 million (Q2 2025).